115 related articles for article (PubMed ID: 10914829)
21. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
[TBL] [Abstract][Full Text] [Related]
22. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
23. Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival.
Nesi G; Palli D; Pernice LM; Saieva C; Paglierani M; Kroning KC; Catarzi S; Rubio CA; Amorosi A
Anticancer Res; 2001; 21(5):3643-9. PubMed ID: 11848537
[TBL] [Abstract][Full Text] [Related]
24. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
25. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
[TBL] [Abstract][Full Text] [Related]
26. [Study on expression of nm23-H1 protein/NDPK-A in laryngeal carcinoma].
Li J; Jin K; Yin S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):247-50. PubMed ID: 11189167
[TBL] [Abstract][Full Text] [Related]
27. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
28. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
30. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
Liu H; Mao H; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
[TBL] [Abstract][Full Text] [Related]
32. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
Liu F; Zhang Y; Zhang XY; Chen HL
J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
lizuka N; Miyamoto K; Tangoku A; Hayashi H; Hazama S; Yoshino S; Yoshimura K; Hirose K; Yoshida H; Oka M
Br J Cancer; 2000 Nov; 83(9):1209-15. PubMed ID: 11027435
[TBL] [Abstract][Full Text] [Related]
34. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
35. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Suman VJ; Harmsen WS; Ziesmer SC; Roche PC; Podratz KC
Gynecol Oncol; 1997 Aug; 66(2):238-45. PubMed ID: 9264569
[TBL] [Abstract][Full Text] [Related]
36. Expression of the p53 and nm23 genes in cholesteatoma.
Bayazit YA; Bakir K; Kanlikama M; Ozer E; Mumbuc S; Disikirik I; Ucak R
Acta Otolaryngol; 2002 Oct; 122(7):726-9. PubMed ID: 12484649
[TBL] [Abstract][Full Text] [Related]
37. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
38. NM23 expression as prognostic factor in colorectal carcinoma.
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
[TBL] [Abstract][Full Text] [Related]
39. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
